...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >CD150 association with either the SH2-containing inositol phosphatase or the SH2-Containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A
【24h】

CD150 association with either the SH2-containing inositol phosphatase or the SH2-Containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A

机译:CD150与含有SH2的肌醇磷酸酶或含有SH2的蛋白酪氨酸磷酸酶的结合由衔接蛋白SH2D1A调控

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

CD15O (SLAM/IPO-3) is a cell surface receptor that, like the B cell receptor, CD40, and CD95, can transmit positive or negatile signals. CD150 can associate with the SH2-containing inositol phosphatase (SHIP), the SH2-containing protein tyrosine phospha-tase (SHP-2), and the adaptor protein SH2 domain protein lA (SH2DtA/DSHP/SAP, also called Duncan’s disease 5112-protein (DSHP) or SLAM-associated protein (SAP)). Mutations in SH2DlA are found in X-linked lymphoproliferative syndrome and non-Hodgkin’s lymphomas. Here we report that SH2D1A is expressed in tonsillar B cells and in some B lymphoblastoid cell lines. where CDl5O coprecipitates with SH2DlA and SHIP. However, in SH2D1A-negative B cell lines, including B cell lines from X-linked lymphoproliferative syndrome patients, CD15O associates only with SHP-2. SH2D1A protein levels are up-regulated b~ CD4O cross-linking and down-regulated by B cell receptor ligation. Using GST-fusion proteins with single replacements of tyrosine at Y269F, Y281F, Y307F, or Y327F in the CD150 cytoplasmic tail, we found that the same phosphorylated Y281 and Y327 are essential for both SHP-2 and SHIP binding. The presence of SH2D1A facilitates binding of SHIP to CD150. Apparently, SH2D1A may function as a regulator of alternative interactions of CDL5O with SHP-2 or SHIP via a novel TxYxxVII motif (immunoreceptor tyrosine-based switch motif (ITSM)). Multiple sequence alignments revealed the presence of this TxYxxV/I motif not only in CD2 subfamily members but also in the cytoplasmic domains of the members of the SHP-2 substrate 1, sialic acid-binding Ig-like lectin. carcinoembryonic Ag, and leukocyte-inhibitory receptor families.
机译:CD150(SLAM / IPO-3)是一种细胞表面受体,与B细胞受体,CD40和CD95一样,可以传递阳性或阴性信号。 CD150可与含SH2的肌醇磷酸酶(SHIP),含SH2的蛋白酪氨酸磷酸酶(SHP-2)和衔接子蛋白SH2域蛋白lA(SH2DtA / DSHP / SAP,也称为Duncan病5112-蛋白(DSHP)或SLAM相关蛋白(SAP))。在X连锁淋巴组织增生综合征和非霍奇金淋巴瘤中发现了SH2D1A的突变。在这里,我们报告SH2D1A在扁桃体B细胞和某些B淋巴母细胞系中表达。其中CD150与SH2D1A和SHIP共沉淀。但是,在SH2D1A阴性B细胞系中,包括来自X连锁淋巴增生综合症患者的B细胞系,CD15O仅与SHP-2相关。 SH2D1A蛋白水平通过CD4O交联而上调,并通过B细胞受体连接而下调。在CD150细胞质尾部的Y269F,Y281F,Y307F或Y327F上使用酪氨酸单取代的GST融合蛋白,我们发现相同的磷酸化Y281和Y327对于SHP-2和SHIP结合都是必不可少的。 SH2D1A的存在促进了SHIP与CD150的结合。显然,SH2D1A可以通过新的TxYxxVII基序(基于免疫受体酪氨酸的开关基序(ITSM))充当CDL50与SHP-2或SHIP相互作用的调节剂。多个序列比对揭示该TxYxxV / I基序不仅存在于CD2亚家族成员中,而且还存在于SHP-2底物1的唾液酸结合Ig样凝集素的细胞质结构域中。癌胚抗原Ag和白细胞抑制受体家族。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号